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Summary 
 
Background: Nephrogenesis is active until 36 weeks’ gestation and may be 
negatively affected by preterm birth. Moreover, potentially kidney-detrimental 
events usually occur during the first phases of post-natal life of preterm infants.  
Little is known about potential endogenous biomarkers other than serum creatinine 
(sCr), such as serum cystatine C (CysC) or beta-trace protein (BTP) in the 
assessment of renal function in preterm newborns.  
Aims: The main aims of the study were to evaluate CysC and BTP levels in preterm 
newborns born at a gestational age (GA) <32 weeks, and to assess the impact of 
pre-natal and post-natal potentially kidney-detrimental factors on kidney function, 
evaluated according to different estimated glomerular filtration rate (eGFR) 
formulas. 
Subjects and methods: newborns with GA<32 weeks were enrolled in our NICU 
in the period September 2015-December 2017. Blood samples were obtained on 
the 3rd day of life (T0) and when they reached a GA of 36 weeks (T36), and sCr, 
CysC, BTP and urea levels were measured. eGFR was calculated according to 9 
existing formulas (Schwartz 2009, Brion, Schwartz 2012, Zappitelli, Filler, 
Dorum, Trieber, Zappitelli-combined) at T36. For each subject, pre-natal and post-
natal kidney injury risk scores were calculated by the number of potentially pre-
natal (intrauterine growth restriction, maternal pre-eclampsia, use of nephrotoxic 
medications during pregnancy, positive family history for arterial hypertension) 
and post-natal (born small for gestational age, need for invasive and non-invasive 
ventilation, bronchopulmonary dysplasia, sepsis, use of nephrotoxic antimicrobic 
agents, ibuprofen or surgery for patent ductus arteriosus, necrotizing enterocolitis, 
intra-ventricular hemorrhage) kidney-detrimental factors.   
Results: We collected data from 71 newborns at T0 (31 with GA£28 weeks) and 
from 53 subjects at T36 (25 with GA£28 weeks). At T0, newborns with GA£28 
weeks had higher sCr levels than those with GA>28 weeks (p=0.016). At T0, sCr 
was negatively correlated with GA (R= -0.315, p=0.009), whereas both CysC and 
BTP were not influenced by GA. At T36, newborns with GA£28 weeks had lower 
sCr, BTP and higher urea levels than those with GA>28 weeks (p=0.007, p=0.005 
and p=0.029, respectively). At T36 eGFR values calculated by the four formulas 
using only CysC were not different in newborns with GA£28 weeks and >28 
weeks. Conversely, eGFR values estimated by other formulas were higher in 
subjects born at a lower GA. The pre-natal score did not correlate with eGFR 
calculated with any formulas. We found a direct correlation between the post-natal 
score and eGFR estimated according to the sCr-based formulas by Schwartz 2009 
(R=0.345, p=0.027) and Brion (R=0.312, p=0.044). However, these correlations 
did not persist when adjusted for urea levels at T36 and GA. Conversely, no 
correlations were found between the scores and eGFR according to the other 
formulas. 
Conclusions: eGFR formulas using CysC are not influenced by GA. Post-natal 
score shows a direct correlation with eGFR according to sCr-based formulas, 
which does not persist after adjustment for GA and urea levels, suggesting that the 
underlying confounder may be the nutritional status of preterm newborns. Indeed, 
more premature subjects receive a more aggressive nutritional regimen, as 
suggested by the higher urea levels found in newborn with GA£28 weeks at T36.  
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Riassunto 
 
Razionale: La nefrogenesi si completa a 36 settimane di gestazione e può essere 
negativamente influenzata dalla nascita pretermine. Inoltre, nelle prime fasi della 
vita dei neonati pretermine spesso si verificano eventi potenzialmente nefrolesivi. 
Ancora scarse sono le conoscenze sull’impiego di marcatori endogeni alternativi 
alla creatinine sierica (sCr), quali cystatine C (CysC) o beta-trace protein (BTP), 
nella valutazione della funzione renale dei nati pretermine.  
Obiettivi: Obiettivi principali dello studio sono stati valutare i livelli di CysC e 
BTP in neonati pretermine con età gestazionale (GA) <32 settimane, e verificare 
l’impatto di fattori pre- e post-natali potenzialmente nefrolesivi sulla funzione 
renale, valutata come estimated glomerular filtration rate (eGFR) calcolato con 
formule diverse. 
Soggetti e metodi: nel periodo Settembre 2015-Dicembre 2017 sono stati arruolati 
presso la nostra Unità di Terapia Intensiva Neonatale i nati di GA <32 settimane. 
Campioni ematici sono stati raccolti in terza giornata di vita (T0) e all’età di 36 
settimane (T36) per il dosaggio di sCr, CysC, BTP e urea. L’eGFR è stato calcolato 
in base a 9 formule esistenti (Schwartz 2009, Brion, Schwartz 2012, Zappitelli, 
Filler, Dorum, Trieber, Zappitelli-combined) al T36. Per ogni soggetto sono stati 
calcolati punteggi di rischio di danno renale pre- e post-natale sulla base del 
numero di fattori potenzialmente nefrolesivi prenatali (ritardo di crescita 
intrauterina, pre-eclampsia materna, uso di farmaci nefrotossici in gravidanza, 
familiarità per ipertensione arteriosa) e post-natali (nato piccolo per l’età 
gestazionale, necessità di ventilazione invasiva e non-invasiva, broncodisplasia, 
sepsi, uso di antibiotici nefrotossici, uso di ibuprofene o intervento 
cardiochirurgico per dotto arterioso pervio, enterocolite necrotizzante, emorragia 
intra-ventricolare).  
Risultati: Abbiamo raccolto i dati di 71 neonati a T0 (31 con GA £28 settimane) 
e di 53 a T36 (25 con GA £28 settimane). A T0, i neonati con GA £28 settimane 
avevano livelli di sCr più elevati dei nati sopra le 28 settimane (p=0.016). A T0, 
sCr correlava inversamente con la GA (R= -0.315, p=0.009), mentre CysC e BTP 
non erano influenzate dalla GA. A T36, i neonati con GA £28 settimane avevano 
livelli più bassi di sCr e BTP e più alti di urea (p=0.007, p=0.005 and p=0.029, 
rispettivamente). A T36 i valori di eGFR calcolato con le quattro formule che 
utilizzano solo CysC non differivano nei nati sotto o sopra le 28 settimane. Al 
contrario, i valori di eGFR stimati dalle altre formule erano più elevati nei soggetti 
nati a GA inferiori. Il punteggio prenatale non correlava con eGFR calcolato 
secondo nessuna formula. Invece, il punteggio post-natale correlava positivamente 
con l’eGFR stimato con le formule basate sulla sCr, la Schwartz 2009 (R=0.345, 
p=0.027) e la Brion (R=0.312, p=0.044). Tuttavia, tali correlazioni non 
persistevano quando pesate per i livelli di urea a T36 e per la GA. Al contrario, il 
punteggio non correlava con l’eGFR stimato con tutte le altre formule. 
Conclusioni: Le formule per eGFR che utilizzano CysC non risultano influenzate 
dalla GA. Il punteggio di rischio post-natale correla direttamente con l’eGFR 
calcolato con formule basate sulla sCr, ma tale correlazione scompare quando 
pesata per GA e livelli di urea, suggerendo che il confondente sotteso a tale 
correlazione potrebbe essere lo stato nutrizionale. Infatti, i soggetti più gravemente 
prematuri ricevono un regime nutrizionale più aggressivo, come testimoniato dai 
maggiori livelli di urea a T36 nei neonati con GA £28 settimane.  
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1. INTRODUCTION 
 
 
Preterm birth and nephrogenesis 
 
The survival of preterm newborns has dramatically improved in the recent decades, 
with babies born as young as 25-week gestation having up to the 80% chance of 
survival.1 Preterm birth has many potential detrimental effects on developmental 
programming, and the kidney is particularly vulnerable to these effects. In the 
human, the first nephrons are formed by 9 weeks of gestation and nephrogenesis is 
completed between 32 and 36 weeks of gestation, with the majority of nephrons 
being formed in the third trimester of pregnancy.2 Any impact on nephron number 
at the very beginning of life may have adverse consequences for life-long renal 
health.3 Emerging epidemiological studies have linked preterm birth with altered 
renal function in childhood and adulthood.4 In addition, preterm birth seems to be 
associated to an increased risk of developing arterial hypertension later in life.5,6 In 
a baboon model,7 whose timing of nephrogenesis and kidney morphology closely 
resembles that of humans, a marked increase of the kidney weight to body weight 
ratio was shown in preterm baboons, compared to control full-term baboons. This 
is likely a compensatory response to the increased functional demands on the 
kidney after preterm birth. There was evidence of ongoing nephrogenesis in the 
outer renal cortex of preterm baboon kidneys at postnatal day 21, with a clearly 
visible nephrogenic zone. Consistent with this, there was an increase in the number 
of glomerular generations formed in preterm kidneys after birth, and an increase in 
the total number of nephrons, albeit at the lower end of the normal range observed 
in term kidneys. Of particular concern, a high number of abnormal glomeruli was 
observed in some of the preterm kidneys. These abnormal glomeruli displayed a 
relatively immature form with scant capillarization, a cystic Bowman’s space, and 
they were only observed in the outer renal cortex, suggesting that the recently 
formed glomeruli or those formed in the extrauterine environment were vulnerable 
to preterm birth. Not all kidneys exhibited abnormal glomeruli with the proportion 
of abnormal glomeruli per kidney ranging from 0.2% to 18.3%. Given the gross 
abnormalities it is considered unlikely that these glomeruli would ever be 
functional. Therefore, the preterm baboons with a high proportion of abnormal 
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glomeruli would have a marked reduction in the endowment of functioning 
nephrons at the beginning of life. To determine whether these abnormalities are 
also present in the kidneys of preterm human infants, a study was performed in 
autopsied kidneys of preterm infants who were born between 24 and 35 weeks of 
gestation and lived for 2–68 days after birth.8 The kidneys from the preterm infants 
were compared with postconceptional age-matched control infants who had died 
acutely in utero. Similar to the preterm baboon kidneys, there was evidence of 
ongoing nephrogenesis in preterm kidneys. The number of glomerular generations 
was significantly increased in preterm kidneys compared with stillbirth controls. 
However, the width of the nephrogenic zone and the proportion of glomeruli in the 
most immature state of differentiation were significantly decreased in the preterm 
kidneys. Taken together, these findings suggest that there may be an accelerated 
postnatal renal maturation following preterm birth. It is not possible to determine 
whether the accelerated development results in the early cessation of 
nephrogenesis. Similarly to the preterm baboon kidneys, there were marked 
glomerular abnormalities in the outer renal cortex in some, but not all, kidneys 
from the preterm infants (ranging from 0% to 13%). In addition, in the normally 
formed glomeruli there was a significant increase in size, indicative of glomerular 
hypertrophy and thus hyperfiltration. The variability in the proportion of abnormal 
glomeruli in the outer renal cortex between preterm infants suggests that there may 
be differences in haemodynamics, and/or other factors in the postnatal environment 
of the infant (such as exposure to nephrotoxic drugs, oxygen supplementation, 
mechanical ventilation and co-morbidities) which may negatively impact 
glomerulogenesis.3 In this regard, there is a major haemodynamic transition at the 
time of birth when blood pressure and heart rate are markedly elevated9 and blood 
flow to the kidneys is increased.10 Hence, it is possible that the developing 
capillaries of immature glomeruli are not prepared for the haemodynamic transition 
at birth and the glomeruli formation may be adversely affected by such a damage. 
Indeed, it has been shown an injury to the aortic wall as a result of preterm birth11 
and it may be supposed that a similar injury occur in preterm glomerular capillaries.   
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Physiology 
 
The human kidney forms from three primordial “attempts” beginning with the 
primitive, but obligatory anlage, called the “pronephros” at about 3 weeks’ 
gestation and lasting for only 3–5 days 12 13 14 15 16. The pronephros provides the 
pattern of ciliated epithelial cells that are reminiscent of the proximal tubular 
epithelial cells that will compose a major part of the human nephron 13 14 15 16. With 
the regression of the pronephros, the mesonephros emerges as a much more 
complex structure with nephrotomes and filtration bundles developing around the 
incursion of the Wolffian duct into the mesonephric mesenchyme. Subsequently, 
the mesonephric nephrons begin their involution and the Wolffian duct gives rise 
to the ureteric bud, which starts its incursion into the metanephric mesenchyme, 
giving rise to the metanephros, the third anlage and true human kidney. From the 
5th gestational week, the ureteric bud begins sequential branching into the 
metanephric mesenchyme propagated by a complex system of signaling molecules 
emanating from both tissues 14 15 16. By the 20th gestational week, the fetal urine 
comprises 80% of the amniotic fluid at a rate of approximately 800 ml per day (300 
ml/kg fetal weight/day) 17 18. Over 80 % of the nephrons form during the last 
trimester, with a rapid succession of “nephron generations” from the cortico-
medullary junction extending up to the “nephrogenic blue zone” under the capsule 
12 19. From 22 to 36 weeks’ gestation, 10–12 generations of nephrons form, similar 
to the rings of a tree 12 19. With cessation of glomerulo-genesis, the nephrogenic 
zone disappears 14 15. Thereafter, only tubular and vascular growth and interstitial 
tissue expansion occurs 14 15. The glomerular epithelial cells are cuboidal in shape 
and the capillary loops are poorly perfused, receiving less than 2 % of the fetal 
cardiac output 17 18.  
It appears that the epithelial cells decrease in density as the nephrons expand with 
the inner glomeruli becoming more “mature”, while those of the outer cortex are 
the last to expand, making them the more vulnerable to adverse circulation ex-utero 
16. 
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Nephron endowment   
 
I. Nephron number 
Based upon autopsy studies, it has been proven that human beings have on average 
approximately 900,000 nephrons per kidney 20 21, and the number declines with 
age 22. However, there is substantial inter-individual variability across different 
populations, even among healthy subjects. In 1934, Moritz and Hayman 23 used the 
acid maceration method to count glomeruli in 14 human kidneys, and they found 
an average glomerular number of 1,282,800 per kidney, with a range of 940,000 to 
1,542,000. When the kidneys of four subjects with “chronic diffuse glomerular 
nephritis” were examined, the glomerular numbers ranged from 155,000 to 
528,000 23. In 1992, Nyengaard et al. published the first study to use unbiased 
stereology to estimate glomerular number in a cohort of 37 healthy Danes. The 
average number of glomeruli in this group was approximately 600,000 per kidney 
ranging from 330,000 to 1.4 million 22. Keller et al. subsequently assessed 
glomerular number in 20 kidneys from middle-aged German subjects killed in 
automobile accidents 24. Among normotensive subjects, the mean number of 
glomeruli was 1.4 million (range 800,000 to 2 million), while hypertensive subjects 
had half as many glomeruli (700,000, range of 530,000–950,000) 24. 
The largest cohort to date was described by Bertram et al. in 2003 and included 
398 subjects with a variety of ethnic and racial backgrounds. The average number 
of glomeruli per kidney reported was 895,711, and there was a greater than tenfold 
variation in nephron number between subjects (ranging from 210,332 to 
2,702,079). In this study, female sex, older age, race (lowest in the Australian 
Aborigines), and low birth weight were all associated with lower nephron number 
20 21.  All the previous studies assessed nephron number in adult subjects, raising 
the possibility that the wide variability in nephron number may be due to pathologic 
or premature loss of nephrons in some patients. Studies on younger subjects have 
found similar results, suggesting that substantial variation in nephron number is 
present from birth. For example, in a study of infants aged <3 months who died of 
congenital abnormalities or sudden infant death syndrome, Zhang et al. found that 
nephron number ranged from 246,181 to 1,106,062 per kidney 25. Unfortunately, it 
must be emphasized that while it may be possible to determine “normal” nephron 
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number, without the ability to prospectively study nephron number in living 
persons, it is impossible to determine the nephron number required for good health 
and maintenance of long-term renal function. 
 
II. Surrogates for nephron number 
Given the intrinsic limitations of autopsy techniques for determining nephron 
number, surrogates have been searched in living subjects. Initial investigations 
found that kidney weight correlated with nephron number 22, so the radiologic 
measurement of kidney size as a surrogate for renal weight, and therefore nephron 
number, has been widely used. Ultrasound-based methods are appealing due to 
their wide availability and non-invasive nature, although they may be limited by 
large inter-observer variability. 
The most significant limitation to radiology-based methods to estimate nephron 
number is that significant hypertrophy (mainly of the tubules) often occurs when 
glomerular number is reduced 26. In the setting of oligonephronia, glomeruli 
enlarge to maintain the total amount of surface area for filtration while the tubules 
show a hypertrophic response to increased filtrate or effective renal plasma flow 27 
28. For instance, in the above described study by Keller et al. 24, glomerular number 
was directly determined after kidney weights were ascertained in 20 subjects who 
died in automobile accidents, ten of whom were known to have arterial 
hypertension. While subjects with hypertension had approximately half as many 
nephrons as the normotensive controls, there was no difference in kidney weight 
between the two groups 24. It has been estimated that only 10 % of the variation in 
nephron number is explained by a difference in renal size in adults 29. For similar 
reasons, glomerular volume has also been proposed as a surrogate for nephron 
number, given the inverse relationship between the size of glomeruli and the 
nephron number 30. Moreover, a clear association between body size and 
glomerular volume was shown, and certain ethnic groups (such as African 
Americans) tend to have larger glomerular volume in general, making this measure 
more difficult to implement in practice. Given the limitations of both radiologic 
and pathologic methods, investigators attempted to combine radiologic and 
pathologic data to obtain better estimates of glomerular number in vivo. Basgen et 
al. proposed that glomerular number could be estimated by measuring the cortical 
volume of the kidney [obtained by magnetic resonance imaging], then multiplying 
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by the fraction of the renal cortex made up of glomeruli divided by the mean 
glomerular volume (obtained by renal biopsy) 31. While there was overall good 
agreement between this approach and the fractionator–dissector method in ten dog 
kidneys, the discrepancy between the two methods varied by up to 36 % for an 
individual kidney. This technique has subsequently been applied in renal transplant 
patients, with renal cortical volume measured by MRI and two percutaneous renal 
biopsy cores used to estimate glomerular number 32. Although the results in 
experimental animals are promising, there has been no method to validate these 
findings in living patients yet.  
 
Factors influencing nephron endowment 
 
I. Prenatal factors 
In humans, nephrogenesis begins at 9 weeks and continues through 32-36 weeks 
of gestation 33 34. Nephrogenesis is a finely orchestrated process that requires 
reciprocal induction of the dividing ureteric bud with the regenerating metanephric 
mesenchyme. Myriad factors—both genetic and environmental—can disrupt this 
delicate balance, leading to aberrant or abbreviated nephrogenesis.  
a) Genetic and epigenetic factors 
As understanding of the human genome expands, the list of genetic factors that 
affect nephrogenesis continues to grow. However, it is clear that the complex 
genetic control of nephrogenesis can be altered at many points, leading to similar 
phenotypes. Mutations affecting nephron number affect either the ureteric bud or 
metanephric mesenchyme. For instance, mutations of Six2 have been discovered 
in patients with renal hypoplasia 35. Six2 is expressed in undifferentiated 
mesenchyme and, when inactivated, there is a reduced number of progenitor cells 
36. Mutations in the ureteric bud or its ability to branch also affect an individual’s 
nephron mass. Infants with a common Ret variant [the RET(1476A) allele] have a 
kidney volume that is 10% smaller than controls 25. Homozygous Ret knockout 
mice do not develop kidneys, while heterozygotes have a reduced nephron number 
37. Ret transcription is regulated by Pax2, and a specific Pax2 haplotype found in 
18.5% of healthy newborns is associated with a 10% reduction in kidney volume 
38. Most of the single gene factors known to alter nephron number are gene 
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disruptions that lead to loss of function and reduced nephron number. However, 
genetic variants may also increase nephron number. El Kares et al. found that 
individuals with a common variant in ALDH1A, present in 20% of healthy 
Caucasians from Montreal, had a 22% increase in kidney volume as newborns 39. 
Moreover, little is known about epigenetic factors involved in kidney development 
40. Histone deacetylases are involved in gene expression via chromatin 
modification. The deletion of class I histone deacetylases causes dysregulation of 
nephron gene expression 41. In animal models of intrauterine growth restriction 
(IUGR), decreased methylation of a promoter ultimately results in increased 
apoptosis and reduced glomerular number 42. More recently, it has been 
demonstrated that histone methylation may affect the cell fate of the metanephric 
mesenychme 43. As earlier discussed, Six2, a renal specific transcription factor, is 
involved in nephrogenesis 44 and the binding of Six2, as well as of beta-catenin, at 
regulatory sites promotes nephron development.  
A better understanding of genetic and epigenetic control of nephrogenesis would 
not only improve our ability to identify patients at a greater risk for their low 
nephron number, but could also identify novel therapeutic targets and strategies. 
 
b) Birth weight 
A low birth weight, either due to premature birth or intrauterine growth restriction, 
seems to negatively affect nephrogenesis. An autopsy study of 56 patients without 
known kidney disease suggested that every 1 kilogram increase in birth weight 
confers an average of 260,000 additional nephrons, with 18 % of the variability in 
nephron number explained by differences in birth weight alone 45. Being birth 
weight determined by a complex interplay of genetic, nutritional, social, and 
obstetric factors, it is extremely challenging to disentangle the effects of a single 
variable from confounders. Many low birth weight infants are premature. However, 
birth weight seem to correlate with nephron endowment independently of 
gestational age. Manalich et al. performed a post-mortem evaluation of 35 infants 
born at >36 weeks of gestation and noted that weight at birth was directly correlated 
with glomerular number and inversely correlated with glomerular size 46. Similarly, 
Hinchliffe et al. observed that nephron number was decreased both in a group of 
six fetuses who died during gestation and eight infants with IUGR who died in the 
first year of life when compared to controls at similar gestational ages 47. It is the 
 
 
12 
asymmetric growth pattern seen in type II IUGR infants (with preservation of brain 
and heart sizes, but a disproportionate reduction in other organs, including the 
kidneys) that is most strongly associated with lower nephron number and an 
increased long-term risk of chronic kidney disease (CKD), as excessive postnatal 
growth can outstrip kidney function 48. While infants with “low birth weight”—
whether from premature birth or IUGR—may share a common phenotype of 
increased CKD risk, the causes of reduced nephron number may differ significantly 
between these groups, requiring distinct strategies or therapeutic interventions to 
protect nephrogenesis in early life in each of these populations. 
 
c) Nutrition 
Nutritional factors play an important role in nephron development, but for obvious 
reasons it is difficult to isolate the effect of particular vitamin, nutrient, or calorie 
deficiencies in observational studies in humans. Reliance on data from animal 
models is therefore necessary. Global caloric restriction has been best evaluated in 
sheep. Sheep given a diet composed of 50% of the calories from the 28th to 80th 
day of gestation then allowed to return to a full diet until the completion of 
gestation (147 days) were found to have a reduced number of nephrons. This 
restriction in calories occurs during a period of rapid placental growth, leading to 
offspring having 10–50% fewer nephrons as adults 49 50. Protein restriction also 
reduces nephron number, although this effect is influenced by both the degree of 
restriction and its timing. In studies with rodents, when mothers received a low 
protein diet throughout gestation but a normal amount of protein postnatally, their 
offspring had a 16–50% decrease in nephron number 51 52 53. Similar findings occur 
even when protein restriction begins at the time of birth, as postnatal nephrogenesis 
occurs in rodents 54. The reduction in nephron number seen in these models may 
be related to increased apoptosis and reduction in the number of progenitor cells 
53. In contrast, high protein diets do not seem to affect offspring nephron number 
55. Iron deficiency in rodents also reduces the nephron number in offspring. Lisle 
et al. 56 exposed pregnant rats to a low iron diet before conception and throughout 
gestation. Pups of these dams had a 23% reduction in glomerular number, although 
there was no difference in kidney weight between control and intervention groups. 
A proposed mechanism for this reduction is that iron deficiency leads to impaired 
hepatic mobilization of vitamin A. Vitamin A reduction, in turn, leads to decreased 
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ureteric bud branching, ultimately reducing nephron number 57. Vitamin A 
modulates nephron number through the regulation of the RET receptor. Expression 
of RET in the ureteric bud tip is exquisitely sensitive to retinoic acid signals from 
adjacent mesenchymal cells, and vitamin A deficiency downregulates the RET 
receptor 58. In rats, there is a strong linear association between plasma retinol and 
nephron number, such that 69% of the variation in nephron number is explained by 
differences in plasma retinol 59. Additionally, postnatal vitamin A supplementation 
can reverse the effect of in utero protein restriction on nephron endowment in 
rodents 60. While nutritional deficiencies generally decrease nephron number, there 
may be exceptions. For instance, when rats were fed a vitamin D-restricted diet 
from the time of conception through lactation, their offspring had a 20% increase 
in nephron number 61. Two mechanisms have been proposed to explain these 
findings. First, active (1,25-OH) vitamin D stimulates cell differentiation and 
inhibits proliferation 62. Alternately, since active vitamin D negatively regulates 
renin expression, increased levels of angiotensin II may stimulate nephrogenesis 63 
64 65 66.  
 
d) Teratogens 
The detrimental effects of fetal exposure to ethanol involving other organ systems 
are well described. Recently, Moritz et al. studied the effects of alcohol on the 
developing kidney and found that ethanol exposure during gestation reduces the 
number of glomeruli by 10–15% in both rodent and sheep models when compared 
to control animals 67 68. Epidemiologic observations suggest that maternal tobacco 
exposure in the form of cigarette smoking during pregnancy affects fetal kidney 
volume in a dose-dependent manner. In a prospective cohort study in the 
Netherlands, the smoking habits of approximately 1,000 mothers were assessed 
during pregnancy and compared to the respective fetus renal volume. As cigarette 
smoke exposure increased, the size of the fetal kidneys decreased compared to a 
control group with no smoke exposure 69. Another established teratogen is 
hyperglycemia, and both in vivo and in vitro studies have demonstrated the 
detrimental effects of hyperglycemia on nephron development. Metanephros 
development is impaired by hyperglycemia 70, and in one study rodent pups born 
to dams with diabetes had up to a 35 % reduction in nephron number compared to 
controls 71. There is similar evidence in humans as well. Adults born to mothers 
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with type 1 diabetes have been found to have smaller increases in glomerular 
filtration rate (GFR) and effective renal plasma flow when subjected to amino acid 
infusion than subjects whose father had diabetes, suggesting reduced functional 
renal reserve 71 72. 
 
e) Medications 
Corticosteroids are frequently administered to women with preterm labor due to 
their benefits in accelerating fetal lung maturity. However, there is evidence that 
steroids alter the expression of key genes involved in the regulation of branching 
morphogenesis 72. Exposing metanephroi culture media to dexamethasone for 2 
days decreases the number of ureteric buds, resulting in fewer nephrons even when 
the dexamethasone is removed 74. The timing of exposure seems important: early 
steroid administration (occurring when the ureteric bud is just invading the 
metanephric mesenchyme) alters nephrogenesis and reduces final nephron number 
by 30% 73 74. Many medications that have nephrotoxic effects in fully developed 
kidneys appear to adversely affect developing kidneys as well. Drugs that disrupt 
the renin–angiotensin system lead to frank renal insufficiency 67, and cyclosporine 
reduces nephron number in animal models 75. The effects of exposure to non-
steroidal anti-inflammatory drugs (NSAIDs), such as cyclooxygenase-2 (COX-2) 
selective inhibitors and acetylsalicylic acid, have shown variable results. Although 
rodents treated with COX-2 inhibitors from either conception or birth over the first 
3 weeks of life had reduced glomerular size, there was no reduction in glomerular 
size if exposure occurred only during gestation 76. Exposure to acetylsalicylic acid 
had no effect on nephron number, but during this experiment the rodents were only 
treated from day 7 to day 20 of gestation 77. In animal studies, in utero gentamicin 
exposure reduced glomerular number by 20%, and offspring developed 
glomerulosclerosis during one year of monitoring 78. Interestingly, some 
nephrotoxic effects seem to be strain specific, such that a reduction in glomerular 
number occurs only in animal strains already susceptible to glomerulosclerosis 79. 
Such findings may have implications for diverse human populations, although it is 
difficult to extrapolate these animal data to human exposures given the variability 
of dose, timing, and follow-up. 
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II. Postnatal factors 
a) Prematurity 
Since nephrons are formed until late gestation, in infants born prematurely kidney 
development presumably continues while in the neonatal intensive care unit. 
Therefore, it is unsurprising that this may result in aberrant nephrogenesis. Our 
understanding of the effects of prematurity comes from a limited number of 
autopsy series and animal studies. Several studies examining the kidneys of 
premature infants have been published in the last decades 8 80 81. Although there 
are risks in applying the results of autopsy studies to living patients, several 
observations are informative. In 2004 Rodriguez et al. found lower radial 
glomerular counts and cessation of glomerulogenesis after 40 days following birth 
in extremely premature infants 82. Sutherland et al. performed a similar study, with 
similar results 8. While these authors found no difference in either the number of 
glomerular generations or total nephron number, there was accelerated renal 
maturation as demonstrated by a reduction in immature glomerular structures 
among the premature infants 8. Both groups reported an increased frequency of 
abnormal glomeruli with increased mesangial tuft and capsular areas and larger 
glomeruli 8. In animal models, the closest approximation to human prematurity is 
the baboon, as it has a relatively long gestation and, if delivered prematurely, can 
be exposed to hyperalimentation, mechanical ventilation, and nephrotoxic 
medications in an intensive care setting. Baboons delivered at 125 (of 185) days 
gestation and harvested at 3 weeks of age had larger kidneys due to enlarged 
glomeruli, although these animals also had decreased glomerular density, shrunken 
tufts, and cystic Bowman’s space 7. There are several limitations with alternative 
animal models. Smaller species, such as rats and mice, continue to develop 
nephrons for several days postnatally 83, and their body size precludes invasive 
methods to sustain life. Nonetheless, there is a recently described mouse model in 
which mice born 1–2 days prematurely develop hypertension, albuminuria, and 
fewer nephrons at 5 weeks of age 84. Although the best evidence of the relationship 
between prematurity and nephron number is derived from autopsy and animal 
studies, renal volume (despite its imperfections) has been frequently examined in 
clinical studies as a surrogate of nephron number. In the youngest group studied, 
Kandasamy et al. examined 68 infants at a corrected gestational age of 38 weeks 
and found lower total renal volume in premature infants 85. Yet when renal volume 
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was corrected for body surface area, the premature group had greater kidney 
volume than full term infants 85. These results are in contrast to studies in older 
children. In a Greek cohort of infants followed for more than 2 years, premature 
infants had a smaller kidney length than their full term controls 86, while a Dutch 
cohort had smaller renal volume in young adulthood than term controls 87. 
Moreover, it has to be pointed out that premature birth and consequent NICU 
staying exposes neonates to many factors, that could be potentially harmful for 
kidney development and health, such a nephrotoxic medications, mechanical 
ventilation with possible hyperoxia, hemodynamic instability, whose singular 
contribution to renal damage may be difficult to disentangle.  
 
b) Acute kidney injury 
There is now convincing evidence that the occurrence of acute kidney injury (AKI) 
is associated with the development of CKD later on. It has recently been proposed 
that AKI and CKD are simply the acute and chronic phases of a single clinical 
syndrome of decreased GFR 88. Central to this hypothesis are the observations that 
AKI leads to nephron loss and tubulointerstitial fibrosis and that reduced nephron 
mass in turn impairs the ability to recover from subsequent injury and accelerates 
CKD progression 89. Since current methods of counting nephrons preclude 
examining nephron number before and after AKI, there is presently no way to 
evaluate the extent to which AKI may occur disproportionately among individuals 
with an already decreased number of nephrons or if nephron loss is dependent on 
a particular type, duration, or developmental timing of injury. 
 
c) Nephrotoxic medications 
Aminoglycoside Antibiotics 
Preterm infants are often exposed in utero and/or immediately after birth to 
antibiotics that could adversely affect nephron formation. Aminoglycosides are the 
most commonly administered antibiotics. Clinical studies have reported that 
postnatal gentamicin exposure leads to a marked increase in the fractional excretion 
of sodium 90 91 and a decrease in GFR 92 93 94 95 96 97 98 as well as an increase in 
urinary protein excretion in preterm neonates. 95 99 100 Therefore, it is essential to 
determine whether postnatal administration of nephrotoxic antibiotics to the 
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preterm neonates may contribute to a reduced nephron endowment and 
consequently reduced renal function later in life. 
Nonsteroidal Anti-Inflammatory Drugs 
Other commonly prescribed therapeutic medications in preterm neonates, 
particularly those born extremely preterm, include the NSAIDs, which are 
prostaglandin inhibitors, administered in order to close a patent ductus 
arteriosus.101. Nonsteroidal anti-inflammatory drugs, such as indomethacin and 
ibuprofen, are known to have detrimental effects for the kidney, particularly the 
developing one.102 In the preterm neonate, administration of NSAIDs has been 
shown to delay the normal increase in GFR that occurs after birth and lead to a 
decrease in urine output.98 103 104 
Hyperoxia 
Postnatal exposure to hyperoxia in the preterm neonate is linked to the 
development of both bronchopulmonary dysplasia and retinopathy of prematurity; 
underlying each of these conditions is impaired angiogenesis.105 106 Results of a 
recent study suggest, however, that microvascular rarefaction may not only be 
confined to the retina and lung, with children born very preterm (30 week 
gestation) demonstrating significantly reduced functional skin capillary density at 
7 to 12 years of age.107 The kidney is a highly vascular organ, with ongoing 
vascularization of the glomeruli occurring following preterm birth. During 
nephrogenesis in utero, the mammalian fetal environment is relatively hypoxic;108 
109 110 rat metanephric organ culture studies have shown low (1%-3%) oxygen 
concentrations to be optimal for both vasculogenesis and tubulogenesis.111 At birth, 
preterm infants are exposed to atmospheric (21%) oxygen levels, and this 
physiologic hyperoxia may be further increased by the use of supplemental oxygen 
during the neonatal period. Therefore, it is conceivable that development of the 
glomerular capillaries will be adversely affected by high oxygen concentrations 
following preterm birth. To date, only one experimental study reports the effects 
of neonatal hyperoxia on the adult kidney in an animal model. Interestingly, 
Yzydorczyk et al 112 demonstrated that nephron endowment was reduced by 25% 
in adult rats (25-35 weeks of age) exposed to hyperoxia during the period of 
postnatal nephrogenesis. However, since the rats were also found to have increased 
blood pressure by 9 weeks of age, it cannot be determined from this study whether 
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the nephron deficit was the result of the exposure to hyperoxia or induced by 
prolonged hypertension. 
 
Assessment of kidney function in newborns 
 
Historically, inulin has been considered the “gold standard” for measurement of 
GFR in infants 113. It is a naturally occurring polysaccharide that is a derivative of 
the Jerusalem artichoke and other legumes such as chicory. It meets the essential 
criteria for accurate measurement of GFR, including being freely filtered through 
the glomerulus and neither being secreted nor re-absorbed in its transit down the 
nephron 114. Moreover, it must not be metabolized or protein bound after injection. 
Importantly, it must be safe and innocuous for clinical investigations in infants and 
children. During the early years of investigation into the renal function of infants, 
there were a number of studies that reported inulin clearances relative to gestational 
and post-natal age 115 116 117 118 119 120. These studies were considered the foundation 
for the assessment of neonatal kidney function and development. Another direct 
method of GFR calculation is the one based on non-radioactive iothalamate 121. 
Although it is partially protein bound and there is possible tubular secretion, it is 
inexpensive and, in the neonate, closely approximates inulin clearance. Iohexol is 
a nonradiopaque contrast agent used in the measurement of GFR in children with 
CKD, but it has not been validated in infants 122. Despite the imperative for having 
a reliable assessment of GFR in the neonate, the performance of clearance studies, 
especially in sick infants, is unfeasible in clinical settings. As a consequence, 
endogenous markers of GFR have been studied and indirect estimating equations 
elabored. To serve as an accurate marker of GFR, the plasma solute must be freely 
filtered across the glomerular membrane and neither secreted nor reabsorbed along 
the tubular network. It must be solely excreted via the kidney and the endogenous 
production rate must be constant.  
 
I. Endogenous markers of kidney function 
The most used endogenous biomarker for the assessment of neonatal kidney 
function is serum creatinine. Creatinine (Cr) is a metabolic product of creatine and 
phosphocreatine found in muscle and as such reflects muscle mass 123 124. Cr 
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concentrations are insensitive to detection of mild to moderate reductions in GFR. 
There is substantial interindividual variability due to differences in muscle mass 
125. In childhood, serum Cr is influenced by age, gender and muscle mass 126. So it 
was necessary to search alternative endogenous biomarkers of GFR, in particular 
low-molecular weight proteins. The idea of using endogenous small molecular 
weight proteins, such as  CysC 127, b-trace protein (BTP) 128, and b-2 microglobulin 
(B2M) 129 130, as markers of GFR is not new 131. Cysteine proteases are proteolytic 
enzymes involved in many pathological processes and are found in the lysosomes 
of cells. They are essential in normal cellular metabolism, being fundamental to 
intracellular protein turnover, degradation of collagen, and cleavage of precursor 
proteins 132. Human cystatin C (CysC) is a low molecular mass protein (13,343 
Da, 120 amino acids) belonging to the cystatin superfamily of reversible inhibitors 
of cysteine proteases of the papain and legumain families 133. In contrast with Cr, 
CysC does not appear to be affected by body muscle mass, age, gender, 
inflammatory state, or nutritional conditions 134. In two meta-analyses, CysC has 
been shown to be a superior marker for the detection of mildly impaired GFR in 
the so called creatinine-blind range 135 136. As for creatinine, CysC is filtered freely 
through glomeruli. The estimation of GFR from CysC does not require information 
about age, sex, ethnicity, weight, or height. Hence, CysC is increasingly being used 
across the world. Based on the latest research, combining CysC and creatinine is 
the most cost-effective way to determine estimated GFR, both in adults and in 
children 137 138. There are limited studies of CysC use to assess GFR in neonates 139 
140 141. Initial studies suggest that CysC does not cross the placenta 142, even if this 
data are controversial. Mothers have increased CysC concentrations toward the end 
of the pregnancy 143 144. It is unclear how the placenta transports CysC. 
Nonetheless, the proportion of CysC reflected by maternal CysC concentrations is 
small. CysC is thus fundamentally different from serum creatinine as only minimal 
amounts cross the placenta, thereby reflecting mostly neonatal function 145.  
Also beta-2 microglobulin (B2M) seems not to cross the placenta. Increased 
serum B2M concentrations have been associated with respiratory distress 
syndrome when compared with healthy control newborns, questioning the 
feasibility of B2M to serve as a marker of neonatal renal function 146.The efficacy 
of measuring neonatal GFR with beta-trace protein (BTP), a 23- to 29-kD enzyme 
consisting in 168 aminoacids,  has not been extensively studied, but it may be a 
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good marker of maternal and neonatal renal function because BTP does not cross 
the placenta at all 147. Ideally, age-independent z-scores of CysC or BTP 
concentrations should be established for postconceptual age using Box–Cox 
transformations and age-independent L, M, and S-scores 147. However, both CysC 
and BTP assays are not routinely available in the hospital chemistry laboratory as 
standard assays and they are 10–15 times more expensive.  
 
II. Normative charts for creatinine, cystatin C, BTP and eGFR 
In the last years, experts have called for the adoption of normative charts for infants 
and children to be able to interpret measures of renal assessment similar to growth 
curves with the calculation of z-scores or percentiles relative to the normal pooled 
data. Traditionally, the dogma has been to dismiss elevated serum creatinine in 
preterm infants during the neonatal period as unreliable. However, there is growing 
concern among pediatric nephrologists and neonatologists that failure to recognize 
kidney injury during the neonatal period may result in a lack of surveillance for the 
detection of AKI and development of progressive kidney disease 148. Table 1 
provides the mean± standard deviation (SD) calculated for preterm and term infants 
at birth and at 3, 6, 12, 24 and 36 months post-conceptual age for serum creatinine, 
cystatin C, and eGFR.  
 
Table 1. Reference values for serum creatinine, Cystatine C, BTP and GFR 
measured by inulin or estimated according to different formulas, in preterm and 
term newborn, and at 3, 6, 12, 24, 36 months. 
 
 
 
 
 
 
*Upper limit of range for adults 
Scr: serum creatinine; ScysC: serum cystatin C; SBTP: serum beta trace protein; GFRINULIN: glomerular filtration rate measured by inulin; 
eGFRcr: estimated GFR by creatinine; eGFRcysC: estimated GFR by cystatin C; eGFRBTP : estimated GFR by beta trace protein 
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Assessment of kidney size in newborns 
 
I. Total kidney volume in the assessment of kidney function 
Preterm birth imposes immediate and potential long-term alterations in kidney size 
and function. Infants born before 36 weeks’ gestation during active nephrogenesis 
will have a decreased number of filtering nephrons and the GFR will be 
proportionate to the number of nephrons being perfused. The GFR will also be a 
function of the gestational age since renal size in utero follows gestational growth 
curves 149. In a small autopsy study of term neonates (n = 15) glomerular number 
correlated to kidney weight 23. This is consistent with adult autopsy studies in 
various populations, suggesting that nephron endowment can be estimated by 
kidney size 22 33 150 151 152 153 154 155. Even more compelling is that kidney size 
individualized to body surface area (BSA) closely correlates with kidney function 
across all age groups156 157 158. Individual kidney volume can be measured using 
the equation for an ellipsoid: volume = length ×width × depth × 0.523 and then left 
and right kidney volumes can be summated for the TKV (ml) 159 160. Ultra-
sonographers can estimate these measurements from standard renal ultrasound 
images. There is a normal Gaussian distribution of TKV individualized to BSA 
(TKV/m2=ml/m2) when measured by non-invasive renal ultrasound from birth to 
adulthood 158. A cross-sectional study of renal ultrasounds in 624 healthy German 
children from birth to 18 years of age showed an average TKV/m2 to be 132 ml/m2 
with the 10th and 90th percent confidence interval being 90 and 171 ml/m2, 
respectively 158. In a Canadian cohort of 136 full-term healthy Caucasian infants 
<3 months of age, an identical curve was generated with the mean 
TKV/m2=132±29 ml/m2 25. The Generation R study of over 6000 Dutch children 
followed prospectively from birth used TKV as a marker of kidney health 161 162. 
When the Gaussian distribution of TKV/m2 of the normal population of 624 
infants, children and adults was superimposed on that of 60 preterm infants at birth, 
the remarkable observation was that they were similar 158. This corroborates 
previous studies that nephron mass and presumed nephron endowment is normally 
distributed and similar in preterm infants at birth. 
The implications are  that, if active nephrogenesis is present in post-natal life, then 
the preterm infant could potentially achieve a nephron endowment similar to that 
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of a term infant. It also suggests that individuals whose TKV/ m2 falls below the 
10th percentile have an inherent risk for “oligonephropathy” and should be 
monitored for hypertension and progression to CKD. In seeking more accurate and 
alternative estimates of GFR in infants and children, it has become evident that 
TKV should be considered in the baseline and longitudinal assessment of neonatal 
kidney function and has implications for the individual’s renal longevity 163 164. 
 
Consequences for adult life 
 
According to the recent data from the Vermont Oxford Network, ~90% of infants 
born weighing 501 to 1500 g survive to NICU discharge, and ~60% of survivors 
leave the NICU without any major neonatal morbidity. 165 Although there has been 
a great deal of research into the neurodevelopmental outcomes of premature 
infants, the impact of prematurity or low birth weight (LBW) on other organ 
systems is less well understood. There is now evidence that premature and LBW 
infants who survive the NICU still face serious risks to their long-term kidney 
health. David Barker is credited with the observation that many “adult” diseases 
may in fact have their origins in fetal life. 166 167 To survive in a stressful or nutrient-
poor environment, a fetus must make “choices” about how to use scarce resources 
in a way that maximizes the likelihood of survival in early life, even at the expense 
of greater susceptibility to chronic illnesses and increased mortality in adulthood. 
This kind of developmental programming among LBW infants 168 169 has been 
associated with problems including obesity, 170 hypertension, 171 insulin resistance, 
172 and coronary artery disease. 173 Nephrologist Barry Brenner first applied 
Barker’s theory to the development of CKD. He hypothesized that either a 
congenital or acquired reduction in nephron number could explain why some 
individuals are more prone to hypertension and CKD. 174 Brenner proposed that 
persons with a decreased nephron number can initially maintain a normal GFR as 
individual nephrons enlarge to increase the total surface area available for renal 
work. Over time, however, this adaptive response becomes harmful. Increased 
glomerular surface area leads to sodium retention and systemic hypertension, and 
glomerular hyperfiltration disrupts renal autoregulatory mechanisms, generating 
intraglomerular hypertension and proteinuria. 175 176 177 These processes eventually 
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cause nephrons to become sclerotic and senescent. This in turn leads to additional 
decline in nephron number and greater hyperfiltration in remnant nephrons, 
culminating in more rapid nephron dropout and perpetuating renal injury in a 
vicious cycle 178 . 
 
I. Prematurity and CKD 
To date, no prospective, population-based studies confirm the association between 
prematurity or LBW and CKD. Although it is difficult to disentangle the effects of 
confounders such as socioeconomic status in retrospective studies, a systematic 
review of 31 cohort or case-control studies found a 70% increase in adulthood CKD 
for LBW infants. 179 Although this meta-analysis excluded studies consisting 
exclusively of extremely LBW or very premature infants, other more inclusive 
analyses showed similar results. A national registry-based study including all 
infants born in Norway from 1967 to 2004 found an overall relative risk of 1.7 for 
the development of end-stage renal disease (ESRD) for infants with birth weight 
<10th percentile compared with those with birth between the 10th and the 90th 
percentile. 180 Clinical signs of oligonephropathy among patients born prematurely 
may be detectable in childhood. 19 181 Two recent case series (each including 50 
infants born at, 30–32 weeks’ gestation) found that children born prematurely had 
smaller kidneys and higher blood pressure compared with term controls, even 
though their GFR remained normal. 89 182 Microalbuminuria, an early indicator of 
kidney disease and a risk factor for future cardiovascular morbidity, 183 is also 
common among children aged 8 to 11 years who were born prematurely or with 
LBW. 184 
 
II. AKI and CKD 
Acute kidney injury in the NICU is not uncommon. Although its overall incidence 
is difficult to determine given the lack of multicenter studies and of a unique 
definition of AKI, the existing studies report an extremely variable incidence of 
AKI among preterm and LBW infants, ranging between 12.5% and 71%. 
Moreover, as the majority of pediatric patients with AKI are discharged from the 
hospital with a normal serum creatinine, 185 the long term significance of their renal 
injury may not be fully appreciated. It was long taught that AKI is reversible. 186 
This may be true for AKI caused purely by volume depletion, but it is now clear 
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that intrinsic forms of AKI cause cumulative and irreversible damage. In animal 
models of acute tubular necrosis, renal regeneration is not complete: there is 
permanent reduction in vascular density and compromised oxygen delivery. 187 188 
Regeneration of tubular epithelial cells can result in sustained fibroblast activation, 
leading to progressive fibrosis even after the initial insult has subsided. 189 There is 
now ample epidemiologic evidence associating AKI with the development of 
CKD, leading some authors even to suggest that the rising incidence of AKI may 
be partly responsible for the nationwide increase in CKD and ESRD. 190 
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2. STUDY AIMS  
 
 
The aims of the study were: to evaluate the performance of endogenous biomarkers 
of kidney function other than serum creatinine, i.e. cystatine C and beta-trace 
protein, in preterm newborns; to evaluate kidney volume measured by 
ultrasonography as a nephronic mass surrogate in preterm newborns; and to assess 
the impact of pre-natal and post-natal potentially kidney-detrimental factors on 
kidney function of preterm newborns. 
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3. SUBJECTS AND METHODS 
 
 
We performed an observational longitudinal study in the Neonatal Intensive Care 
Unit (NICU) of Maggiore della Carità University Hospital, Novara, a tertiary level 
perinatal center. We enrolled all the preterm babies with a GA £32 weeks born 
between September 2015 and December 2017. Exclusion criteria were the presence 
of prenatally detected kidney anomalies and complex syndromes or congenital 
anomalies. 
 
Preterm babies were enrolled at birth and assessments were performed at two time 
points: T0, on the 3rd day of life, and T36, when they reached a GA of 36 weeks.  
The timing of T0 was chosen on the basis that it is known that serum creatinine 
values are influenced by maternal ones in the first 48-72 hours after birth. Babies 
who were discharged or moved to other hospitals or died before 36 weeks GA only 
had the T0 assessment.  
 
Anamnestic data 
From medical records, we collected for each subject the following data: gender, 
GA, birth weight and birth weight category (AGA, if birth weight was appropriate 
for gestational age; SGA, if small for gestational age, with a birth weight lower 
than 10th centile for sex and GA; LGA, if large for gestational age,  with a birth 
weight higher than 90th centile), single/twin pregnancy, delivery mode, mother’s 
and father’s age at the time of delivery, use of medications during pregnancy -in 
particular potentially nephrotoxic drugs-, positive family history for arterial 
hypertension (within the second degree of kinship), history of intrauterine growth 
restriction (IUGR) or maternal pre-eclampsia, maternal serum creatinine value at 
the time of delivery. GA was determined by fetal ultrasound and projected date of 
delivery by last menstrual period. INeS charts 191 were used to evaluate birth weight 
category. Nephrotoxic drugs administered to the mothers included betamethasone 
192, non-steroidal anti-inflammatory drugs 193, anti-hypertensive drugs 194, anti-
microbial agents 195. 
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Clinical course data 
From our NICU dataset, we collected for each subject the following data: the need 
for invasive ventilation and its duration, the need for non-invasive ventilation and 
its duration, the length of need for O2-support, the development of 
bronchopulmonary dysplasia (BPD), the development of sepsis, the use and 
duration of antibiotic therapy – especially nephrotoxic drugs (gentamicin, 
vancomycin) -, the presence of patent ductus arteriosus (PDA), needing a 
pharmacological (ibuprofen) or surgical approach, the development of necrotizing 
enterocolitis (NEC), the development of intra-ventricular hemorrhage (IVH), the 
length of NICU staying. 
The durations are expressed as number of days. The Yes/No items were used to 
create two kidney injury risk scores (each “Yes” answer accounting for 1 point), 
prenatal and postnatal ones, given by the sum of all the “Yes” answers to the 
presence of potential risk factors for kidney injury (Table 2). A total score was 
finally calculated by the sum of the pre-natal and post-natal kidney injury risk 
scores.  
 
Table 2. Items considered in pre-natal and post-natal kidney injury risk scores: 
each Yes answer accounts for 1 point.  
Pre-natal kidney injury risk score Post-natal kidney injury risk score 
Intrauterine growth restriction (IUGR)  Born small for gestational age (SGA) 
Maternal pre-eclampsia Need for invasive ventilation 
Nephrotoxic medications during 
pregnancy 
Need for non-invasive ventilation 
Positive family history for arterial 
hypertension 
Bronchopulmonary dysplasia 
 Sepsis 
 Use of nephrotoxic antimicrobic 
agents 
 Ibuprofen for patent ductus arteriosus 
(PDA) 
 Surgery for patent ductus arteriosus 
(PDA) 
 Necrotizing enterocolitis (NEC) 
 Intra-ventricular hemorrhage (IVH) 
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Anthropometric measurements 
Weight and length were measured at both T0 and T36. Birth weight was measured 
using an electronic weighing scale integrated into the incubator until the babies 
were taken in the incubators, and then by an electronic infant weighing scale. The 
length measurement (head to toe) was carried out with the infant lying supine and 
with the body, hips, and knees straightened; measurements were taken twice and 
then averaged. Body surface area (BSA) was calculated according to Haycock  
formula: BSA (m2) = 0.024265 x L (cm) 0.3964 x weight (kg) 0.5378. 
 
Biochemical parameters 
Venous or arterial blood samples were collected at T0 and T36 for clinical reasons, 
and serum creatinine (sCr), cystatin C (CysC), beta-trace protein (BTP) and urea 
were measured.    
sCr: was measured on ADVIA Chemistry 1800 or ADVIA Chemistry XPT with 
an enzymatic assay. This method is considered more specific and reliable than all 
the Jaffé modified methods. The analytical variability coefficient was  < 3%. 
Cys C: was measured with BN II/ BN ProSpec® by amplified latex 
immunophelometry.  
BTP: was measured on serum sample with N Latex BTP system. N Latex BTP is 
BTP specific.  
Urea: was measured on ADVIA Chemistry 1800 or ADVIA Chemistry XPT using 
the glutamate dehydrogenase lined enzyme assay system. The analytical variability 
coefficient was < 2.5 %. 
 
Estimated glomerular filtration rate (eGFR) was calculated according to 9 existing 
formulas, including creatinine in 2 cases, CysC in 5 cases, BTP in 1 case and 
combining sCr and CysC in 1 case. The applied formulas were: 
1. eGFR Schwartz 2009: 0.413 x lenght/sCr      [196] 
2. eGFR Brion: 0.33 x lenght/sCr       [197] 
3. eGFR Schwartz 2012: 70.69 x (CysC) -0.931   [198] 
4. eGFR Zappitelli: 75.94 x (CysC) -1.170    [199] 
5. eGFR Filler: 91.62 x (CysC) -1.123     [200] 
6. eGFR Dorum: 74.835 x (CysC) -0.750    [201] 
7. eGFR Treiber: [(TKV/BSA)/CysC]/1.73    [202] 
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8. eGFR Benlamri: 10 (1.902+(0.9515 x LOG(1/BTP)))    [203] 
9. eGFR Zappitelli-combined: (43.82 x e 0.003 x L) / (CysC 0.635 x sCr 0.547)  
         [204] 
Urinary parameters 
Only at T36 a urine sample was collected, due to the difficulty to collect an 
adequate urine volume at T0. Urine samples were centrifuged to remove 
particulates and assayed immediately or aliquoted and stored frozen. On urine 
samples creatinine (uCr), albumin (uAlb), protein (uProt), beta2microglobulin 
(uB2M) and KIM-1 were measured. These values were normalized to uCr 
concentration.   
uCr: was measured on ADVIA Chemistry 1800 or ADVIA Chemistry XPT with 
an enzymatic assay, which is considered more specific and reliable than all the 
Jaffé modified methods. The analytical variability coefficient was  < 3%. 
uAlb: was measured on ADVIA Chemistry 1800 or ADVIA Chemistry XPT using 
an immunoturbidimetric assay system. The analytical variability coefficient was 
<5.5 %. 
uProt: was measured on ADVIA Chemistry 1800 or ADVIA Chemistry XPT 
using a dye-binding (pyrogallol red) assay. The analytical variability coefficient 
was <5%. 
uB2M: was measured on LIAISONâ analyzer using an immunoassay kit.  
KIM-1: was measured by a human ELISA kit (BioVendor, Laboratorni Medicina 
a.s., Brno, Czech Republic), as recommended by the manufacturer.  
uAlb/cCr was considered pathological if >0.3, uProt/uCr if >0.5, uB2M/uCr if 
>100, and uKIM-1/uCr if >0.0036 [Pennemans V, Rigo JM, Faes C, Reynders C, 
Penders J, Swennen Q. Establishment of reference values for novel urinary 
biomarkers for renal damage in the healthy population: are age and gender an 
issue? Clin Chem Lab Med. 2013Sep;51(9):1795-802.]. 
 
Kidney ultrasonography 
At T0 and T36 a kidney ultrasonography (US) was performed to evaluate kidney 
size. Philips HD7XE Ultrasound System with a compact (small footprint) curved 
linear 5–8 MHz frequency transducer was used. To avoid inter-observer bias 
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during scanning and measuring, all ultrasound scans of the kidneys were performed 
by a single neonatologist, skilled in renal US.  
Renal length, anteroposterior diameter (width), and transverse diameter (depth) 
were measured for both kidneys. Kidney volume (KV; ml) was calculated by the 
equation for an ellipsoid: 
volume = length x width x depth x π/6.  
Total kidney volume (TKV) was calculated by the sum of left and right kidney 
volumes, and its ratios to weight, length and BSA were calculated too. 
 
Statistical analysis 
Data were expressed as mean ± SD, for continuous variables, and as number and 
percentage (%), for categorical variables.  
For some analyses, subjects were divided into two subgroups according to 
gestational age (£ and > 28 weeks). Comparisons between groups were performed 
using Kruskal-Wallis ANOVA and Mann-Whitney U test, as appropriate. 
Comparisons between paired data (T0 vs T36) were performed by Wilcoxon signed 
rank test. Correlations between continuous variables were evaluated by Spearman 
rank order correlation.  
A p value of < 0.05 was considered statistically significant. All analyses were 
performed using SPSS version 21.0 (IBM, New York, NY, USA). 
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4. RESULTS 
 
We enrolled 71 newborns (M:F=37:34), admitted from December 2015 to January 
2018 to Maggiore della Carità Hospital NICU, born between 24 and 32 weeks of 
gestational age (mean GA 28.5±2.16). Out of them, 31 (43.7%) had a gestational 
age £ 28 weeks. For all the 71 enrolled newborns anamnestic, anthropometric, 
biochemical and US data were collected at T0. At T36 clinical course, 
anthropometric, biochemical, urinary and US data could be collected for 53 
patients, since 5 newborns (7%) were dead and 13 (18.3%) were back-transferred 
before 36 weeks GA to other peripheral second-level Neonatology Unit. 
 
Anamnestic data  
The delivery mode was vaginal eutocic delivery in 13 newborns (19.4%), vaginal 
dystocic delivery in 1 (1.5%), and caesarean section in 53 (79.1%). Sixty-one 
neonates were singletons (85.9%) and 10 were twins (14.1%). Prenatal data were 
drawn from medical records: a history of intra-uterine growth restriction (IUGR) 
was reported in 12 neonates (16.9%), pre-eclampsia of the mother in 20 (28.2%), 
administration of at least one potential nephrotoxic drug in 54 mothers (76.1%). In 
25 newborns (35.2%) a positive family history (within the second degree of 
kinship) for arterial hypertension was reported. Seven newborns (9.9%) were 
classified as SGA. Mean mother’s age at the delivery was 33.9 ± 5.5 years, and 
mean father’s age was 36.5 ± 6.9 years. 
Mean serum creatinine level of the mother at the time of delivery was 0.64 ± 0.25 
mg/dl (range 0.30-1.41), being significantly higher in pre-eclamptic mothers (0.82 
± 0.26 vs 0.51 ± 0.13 mg/dl, p<0.0001). 
Mean creatinine level of the newborns measured in the first day of life was 0.92  ± 
0.22 mg/dl (range 0.36-1.63), without difference according to gender or gestational 
age. It was positively correlated with maternal creatinine levels at the time of 
delivery (R=0.593, p<0.0001 ). 
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Anthropometric data 
Anthropometric data at T0 and T36 are shown in Table 3.   
At T0, all anthropometric parameters were significantly lower in newborns with 
GA£28 w (p<0.0001 for each), whereas at T36 they were not different in the two 
GA groups.  
No differences were found in any of the anthropometric measures according to 
gender at T0, whereas at T36 males had higher weight, height and BSA (p=0.03 
for each). 
 
Table 3. Anthropometric data in the overall population and in subjects with GA £ 
or >28 weeks, at T0 and T36.   
 T0 T36 
Overall 
(n=71) 
GA£28 w 
(n=31) 
GA>28 w 
(n=40) 
Overall 
(n=53) 
GA£28 w 
(n=25) 
GA>28 w 
(n=28) 
Weight 
(g) 
1084±380 
(490-2236) 
829±215* 
(490-1450) 
1281±363* 
(580-2236) 
1863.7±358.3 
(950-2795) 
1861±373 
(1360-2795) 
1866±350 
(950-2460) 
Length 
(cm) 
36.4±4.1 
(28-46) 
33.5±3.2** 
(28-40) 
38.6±3.4** 
(30-46) 
41.8±2.7 
(36-48) 
41.8±2.5 
(37-48) 
41.8±2.8 
(36-47) 
BSA  
(m2) 
0.104±0.024 
(0.062-0.169) 
0.088±0.015§ 
(0.062-0.128) 
0.117±0.216§ 
(0.069-0.169) 
0.149±0.018 
(0.097-0.196) 
0.149±0.018 
(0.126-1.196) 
0.148±0.019 
(0.097-0.180) 
*, **, § p<0.0001 
 
 
 
Clinical course data 
 
Clinical course data are shown in Table 4. 
The pre-natal and post-natal kidney injury risk scores were evaluated from some 
anamnestic and clinical course data, and the total kidney injury risk score was 
calculated. In the overall group, the mean pre-natal, post-natal and total scores were 
1.5±0.9, 3.6±1.6 and 5.1±2.1, respectively. Comparing the group of subjects with 
GA £28 weeks and >28 weeks, the pre-natal score was similar (1.4±0.9 vs 1.6±0.9, 
NS), whereas the post-natal and the total scores were significantly higher in the 
subjects with lower GA (post-natal score 4.5±1.6 vs 2.9±1.3, p<0.0001, total score 
5.8±2.1 vs 4.5±1.8, p=0.02).  
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Table 4. Clinical course data of the 53 subjects at T36, in the overall group and 
according to GA. 
 Overall 
(n=53) 
GA£28 w 
(n=25) 
GA>28 w 
(n=28) 
p 
Need for invasive 
ventilation (n, %) 
30 (56.6%) 17 (68%) 13 (46.4%) NS 
Duration of 
invasive 
ventilation  
(days, mean±SD) 
8.1±13.9 12.4±15.9 4.4±10.8 0.02 
Need for non-
invasive 
ventilation (n, %) 
48 (90.6%) 25 (100%) 23 (82.1%) 0.02 
Duration of non-
invasive 
ventilation (days, 
mean±SD) 
17.5±15.9 29.1±15.4 7.2±6.6 <0.0001 
length of need for 
O2-support  
(days, mean±SD) 
22.8±44 37.3±51.7 9.9±31.4 0.007 
BPD (n, %) 14 (26.4%) 12 (48%) 2 (7.1%) 0.001 
Sepsis (n, %) 9 (17%) 6 (24%) 3 (10.7%) NS 
Length of 
antimicrobial 
therapy  
(days, mean±SD) 
17.7±14.6 24.3±17.2 11.8±8.6 0.002 
Use of 
nephrotoxic 
antibiotics (n, %) 
50 (94.3%) 24 (96%) 26 (92.9%) NS 
PDA treated with 
ibuprofen (n, %) 
19 (35.8%) 13 (52%) 6 (21.4%) 0.02 
PDA treated with 
surgery (n, %) 
5 (9.4%) 4 (16%) 1 (3.6%) NS 
NEC (n, %) 5 (9.4%) 4 (16%) 1 (3.6%) NS 
IVH (n, %) 12 (22.6%) 9 (36%) 3 (10.7%) 0.03 
Length of NICU 
staying  
(days, mean±SD) 
65.2±34.5 83±35 50.7±26.7 <0.0001 
Parenteral 
nutrition (n,%) 
40 (75.5%) 25 (100%) 15 (53.6%) <0.0001 
 
 
Biochemical and US data  
Biochemical and US data at T0 and T36 data are shown in Table 5. 
No differences were found for any of the biochemical and US data according to 
gender at T0, whereas at T36 TKV was significantly higher in males than in 
females (p=0.03). 
At T0, newborns with GA£28 weeks had higher sCr levels and TKV/weight than 
those with GA>28 weeks (p=0.016 and p=0.023, respectively). At T36, newborns 
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with GA£28 weeks had lower sCr, BTP and higher urea levels than those with 
GA>28 weeks (p=0.007, p=0.005 and p=0.029, respectively). 
All the other biochemical and US data were not different according to gestational 
age both at T0 and T36.    
 
Table 5. Biochemical and US parameters at T0 and T36, in the overall population 
and according to GA.  
 Overall GA£28 w GA>28 w 
 T0 
(n=71) 
T36 
(n=53) 
p T0 
(n=31) 
T36 
(n=25) 
p T0 
(n=40) 
T36 
(n=28) 
p 
sCr (mg/dl) 0.83±0.22 0.30±0.07 <0.0001 0.88±0.22 0.27±0.07 <0.0001 0.79±0.22 0.33±0.05 <0.0001 
CysC (mg/l) 1.57±0.33 1.46±0.29 NS 1.62±0.41 1.38±0.35 0.008 1.54±0.25 1.55±0.19 NS 
BTP (mg/l) 1.484±0.464 1.299±0.381 NS 1.339±0.418 1.128±0.306 NS 1.583±0.474 1.48±0.374 NS 
Urea 
(mg/dl) 
22.3±1.4 9.8±6.9 NS 25±12.9 12.5±7.9 NS 21.3±11.3 7.36±4.84 NS 
TKV (ml) 11.66±4.57 16.59±5.24 <0.0001 10.27±4.09 17.69±5.84 0.001 12.67±4.69 15.6±4.56 0.002 
TKV/height 
(ml/cm) 
0.314±0.104 1.223±0.433 <0.0001 0.302±0.113 1.275±0.558 0.001 0.323±0.097 1.17±0.27 <0.0001 
TKV/weight 
(ml/g) 
0.011±0.004 27.405±10.326 <0.0001 0.012±0.004 28.337±12.96 0.001 0.009±0.002 26.519±5.238 <0.0001 
TKV/BSA 
(ml/m2) 
109.46±34.34 342.32±122.87 <0.0001 114.44±42.85 355.04±156.66 0.001 105.87±26.69 330.24±81.4 <0.0001 
 
eGFR values estimated according to nine previously described formulas are shown 
in Table 6. No differences were found in newborns with GA£28 weeks and >28 
weeks calculating eGFR by the four formulas using only CysC. Conversely, eGFR 
values estimated by other formulas were higher in subjects born at a lower GA.  
 
Table 6. eGFR values at T36 calculated by nine different formulas, in the overall 
population and according to GA. All eGFR are expressed in ml/min/1.73 m2. 
 
 T36 
Overall 
(n=53) 
GA£28 w 
(n=25) 
GA>28 w 
(n=28) 
p 
eGFR Schwartz 2009 59.5±15.1 65.7±17.1 53.2±9.5 0.012 
eGFR Brion 47.5±12 52.5±13.6 42.5±7.6 0.012 
eGFR Schwartz 2012 51.8±12 55.7±15 47.6±5.3 NS 
eGFR Zappitelli 51.9±15.7 56.9±19.6 46.3±6.5 NS 
eGFR Filler 63.5±18.3 69.3±22.9 56.9±7.6 NS 
eGFR Dorum 48.8±17.2 54.3±21.6 42.6±6.8 NS 
eGFR Treiber 45.2±16.5 51.1±19.7 37.9±6.4 0.04 
eGFR Benlarmi 66.9±18 75.3±18 58±13.4 0.005 
eGFR Zappitelli-
combined 
80.1±20.9 88.7±23.8 69.4±9.5 0.009 
 
 
 
35 
Urinary data 
Urinary parameters are reported in Table 7. 
No differences were found for all urinary parameters according to GA groups. 
Considering the percentages of pathological ratios, we found that uAlb/uCr was 
pathological in 13.6% of overall newborns (19% in newborns with GA£28 w vs 
8.7% in those with GA >28 w, NS), uProt/uCr was pathological in 76.7% of overall 
newborns (80% in newborns with GA£28 w vs 73.9% in those with GA >28 w, 
NS), uB2M/uCr was pathological in 75% of overall newborns (78.9% in newborns 
with GA£28 w vs 71.4% in those with GA >28 w, NS), and uKIM-1/uCr was 
pathological in all the newborns. 
 
Table 7. Urinary parameters according in the overall group and according to GA 
at T36. 
 T36 
Overall 
(n=53) 
GA£28 w 
(n=25) 
GA>28 w 
(n=28) 
uAlb/uCr  0.13±0.12 
(0.01-0.58) 
0.12±0.1 
(0.01-0.39) 
0.16±0.14 
(0.02-0.3) 
uProt/uCr 0.96±0.68 
(0.18-3.8) 
0.9±0.78 
(0.18-3.8) 
1.02±0.57 
(0.25-2.31) 
uB2M/uCr 261.4±217.6 
(18.2-1052.6) 
220.4±145.3 
(18.2-472.9) 
306.6±273.8 
(18.3-1052.6) 
uKIM-1/uCr 0.084±0.046 
(0.026-0.203) 
0.085±0.042 
(0.032-0.157) 
0.084±0.049 
(0.026-0.203) 
 
Correlation analyses 
At T0, sCr values were positively correlated with CysC and BPT levels (R=0.415, 
p=0.01 and R=0.274, p=0.04, respectively). CysC and BTP were not correlated. 
Neither sCr nor CysC nor BTP correlated with urea. At T0, sCr was negatively 
correlated with GA (R= -0.315, p=0.009), whereas both CysC and BTP were not 
influenced by GA. 
T0 levels of sCr, CysC and BTP did not correlate with either maternal sCr levels 
or anthropometric parameters at birth, even when adjusted for GA. 
At T0, sCr levels were negatively correlated with TKV, TKV/length and 
TKV/BSA (R= -0.344, p=0.008, R= -0.333, p=0.01 and R= -0.258, p=0.049, 
respectively). Conversely, urea levels at T0 were positively correlated with TKV 
(R=0.615, p=0.04). Neither CysC nor BTP showed significant correlation with any 
of the US parameters. 
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TKV at T0 was positively correlated with GA (R=0.427, p=0.001), birth weight, 
length and BSA (R=0.6, p<0.0001 for each). 
At T36, sCr values were positively correlated with CysC and BPT levels (R=0.527, 
p=0.001 and R=0.494, p=0.003, respectively), similarly to T0. CysC and BTP were 
directly correlated (R=0.531, p=0.001). Neither sCr nor CysC nor BTP correlated 
with urea at T36. Levels of sCr, CysC, BTP and urea did not correlate with body 
weight, length and BSA at T36. Biochemical parameters and kidney volumes were 
not correlated at T36. The T36 levels of sCr, CysC and BTP were all directly 
correlated with GA (R=0.469, p=0.001; R=0.317, p=0.046; and R=0.482, p=0.002, 
respectively). 
Among urinary parameters, uProt/uCr was positively correlated with both BTP and 
urea at T36 (R= 0.404, p=0.02, and R=0.503, p=0.03, respectively). uProt/uCr was 
also positively correlated with TKV/weight (R=0.346, p=0.039) and TKV/BSA 
(R=0.330, p=0.049). uKIM-1/uCr was positively correlated with TKV/weight 
(R=0.509, p=0.018), TKV/length (R=0.453, p=0.039) and TKV/BSA (R=0.492, 
p=0.023).  
eGFR according to any formula did not correlate with anthropometric parameters 
at T36. eGFR was negatively correlated with GA (R= -0.389, p=0.01 for 
Schwartz2009’s formula, R= -0.389, p=0.01 for Brion’s formula, R= -0.371, 
p=0.048 for Treiber’s formula, R= -0.424, p=0.01 for Zappitelli-combined 
formula, and R= -0.458, p=0.003 for Benlarmi’s formula; eGFR estimated 
according to all the other formulas tended to be negatively correlated, p=0.05), but 
the correlation did not persist when adjusted for weight, length, and urea levels at 
T36. 
Both post-natal and total kidney injury risk scores were negatively correlated with 
GA (R=-0.552, p<0.0001, and R=-0.296, p=0.012, respectively). 
Anthropometric measures at T36 are influenced by the kidney injury risk scores. 
Indeed, weight at T36 was negatively correlated with pre-natal, post-natal and total 
scores (R= -0.533, p<0.0001; R= -0.337, p=0.02; and R=-0.389, p=0.005, 
respectively), also when adjusted for GA. Likewise, length at T36 was negatively 
correlated with pre-natal and total scores (R= -0.422, p=0.003; and R=-0.434, 
p=0.002, respectively), also when adjusted for GA. Similarly, BSA at T36 was 
negatively correlated with pre-natal, post-natal and total scores (R= -0.518, 
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p<0.0001; R= -0.357, p=0.015; and R=-0.480, p=0.001, respectively), also when 
adjusted for GA. 
No correlation was found between the kidney injury risk scores and kidney 
volumes. 
We evaluated the impact of kidney injury scores on eGFR estimated according to 
different formulas. The pre-natal score did not correlate with eGFR calculated with 
any formulas. We found a direct correlation between the post-natal and total scores 
and eGFR estimated according to Schwartz 2009 (R=0.345, p=0.027 for both) and 
Brion’s formulas (R=0.312, p=0.044 for both). However, these correlations did not 
persist when adjusted for weight, length and BSA at T36. The correlations did not 
persist also when adjusted for urea levels at T36 and GA. Conversely, no 
significant correlations were found between the scores and eGFR according to the 
other formulas. 
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5. DISCUSSION 
 
In our study, data from a cohort of preterm babies admitted to NICU born between 
24 and 32 weeks of GA, were collected in the 3rd day of life and at a post-menstrual 
age of 36 weeks. 
The first aim of the study was to evaluate in preterm newborns the performance of 
endogenous biomarkers of kidney function, serum cystatine C and beta-trace 
protein, in addition to traditional serum creatinine measurement. We found that 
CysC and BTP levels measured in the 3rd day of life in our NICU population are 
comparable to the reference ranges reported in literature for premature infants of 
similar gestational age140. 
In our population we found that at T0 only sCr values were negatively correlated 
with GA, whereas CysC and BTP were not. None of the biomarkers were 
influenced by gender or anthropometric parameters at T0. Our results are consistent 
with previous data by Armangil et al in a cohort of preterm newborns with a mean 
GA slightly higher than ours 205. Similarly, Elmas et al reported that CysC values 
measured on the 3rd day of life were independent of gestational age, birth weight 
and gender 206. The lack of correlation we found between BTP and GA in our cohort 
was previously described by Filler et al both in preterm and term newborns 207.  
Creatinine levels on the 1st day of life largely reflects maternal levels, making this 
marker useless in clinical practice to assess alterations in kidney function of the 
newborn and supporting the evidence that creatinine crosses the placenta 208. Soon 
after birth, there is a strong correlation between maternal and newborn creatinine 
which is lost subsequently: in fact in our study we found no correlation between 
maternal Cr and newborn’s Cr on the third day of life.  
At T36, sCr and BTP levels were lower in subjects with lower GA. One could 
hypothesize that the lower sCr values may be the hallmark of a worse nutritional 
state and of a reduced muscle mass. Actually, the higher urea levels in infants with 
GA £28 weeks seem to contradict this hypothesis. Therefore, it could be argued 
that the reduced levels of sCr and BTP found in subjects with lower GA may 
indicate a better kidney function. In our cohort CysC values are independent of GA 
at T36. All the three biomarkers are not influenced by anthropometric measures at 
T36. Intuitively, as a consequence of the lower sCr and BTP levels, in the group of 
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infants born before 28 weeks GA also the eGFR calculated by formulas using sCr 
or BTP (Schwartz 2009, Brion, Treiber, Benlarmi and Zappitelli-combined) were 
significantly higher. Interestingly, we found the unexpected result that eGFR was 
negatively correlated with GA, apparently indicating that subjects born at a lower 
GA have a better renal function at T36. However, the correlations did not persist 
when adjusted for weight, length, and urea levels at T36. Therefore, we may 
hypothesize that the confounder underlying this association actually is the 
nutritional status of preterm newborns. Indeed, in subjects born before the 28 
weeks of GA anthropometric measures at T0 were significantly lower than in those 
with GA>28 weeks, but these differences did not persist at T36. This may be 
probably due to the fact that more premature subjects receive a more aggressive 
and careful nutritional regimen, as suggested by the higher urea levels found in 
newborn with GA£28 weeks at T36. This hypothesis may also be supported by the 
significantly higher percentages of subjects receiving parenteral nutrition in the 
group born before 28 weeks of GA. Indeed, all newborns with GA£28 weeks 
received parenteral nutrition, whereas only half of the subjects with GA >28 weeks 
did.  
Furthermore, it has to be highlighted the high variability in eGFR calculated 
according to the nine formulas, both in the overall population and into the GA 
groups. Abitbol et al 149 showed in preterm and term infants that Cr-based equations 
consistently underestimated GFR, whereas CysC and combined equations were 
more consistent with reference inulin clearance studies. 
 
In our study, kidney function at T36 was also evaluated in terms of urinary 
excretion of proteins, potentially aiming to differentiate a glomerular (albumin) 
from a tubular (B2M, KIM-1) damage. We found no differences in any of the 
urinary markers according to GA. However, values higher than upper limits may 
be noted for total urine protein, albumin, B2M and KIM-1, all corrected for urinary 
creatinine values. And when pathological ratios are considered, over three fourth 
of overall newborns showed pathological levels of proteinuria, that may be mainly 
due to the tubular components, as we can see by the fact that only 13.6% of subjects 
had pathological albuminuria, whereas normalized B2M and KIM-1 values were 
abnormal in 76.7% and 100% of newborns, respectively. Therefore, preterm birth 
and NICU staying seem to impact more on tubular than on glomerular function. 
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Up to now, only a few studies have investigated the occurrence of proteinuria 
following preterm birth. A high variation in urine albumin levels among preterm 
neonates has been shown, with the highest levels in those with a lower gestational 
age at birth and those that were clinically unstable 209 210 211. Urinary levels of B2M 
have also been shown to be significantly higher in the preterm than in term 
newborns throughout the first month of life 211 212. Also pathological proteinuria 
has been previously reported in preterm neonates, possibly associated with renal 
immaturity and/or acute kidney injury.213 
 
The second aim of our study was to evaluate kidney volume measured by 
ultrasonography as a nephronic mass surrogate. The main limitation to this aim was 
the lack of a gold standard, because we did not know the actual nephron number of 
our patients, being it possible only in post-mortem evaluations. Nonetheless, at T0 
we found that sCr levels were negatively correlated with kidney volumes. In the 
recent paper by Ardissino et al 214, the Authors hypothesized that sCr measured in 
the first 2-4 days of life, representing the period of maximum physiological 
perinatal dehydration, could be a reliable indirect measure of nephron endowment 
in full-term newborns. Likewise, our results confirm such hypothesis in a cohort of 
preterm newborns, assuming that kidney volume is considered a proxy measure of 
nephron number. However, this seems no more true at a post-menstrual age of 36 
weeks, when the essential unmasking effect of dehydration is missing and the link 
between sCr and kidney volume does not persist.  
We found that, at T0, TKV was positively correlated with both GA and 
anthropometric measures. A smaller kidney volume in neonates with lower 
gestational age was also reported by Kandasamy et al 85. They also reported that 
preterm babies <32 weeks GA showed a higher TKV pro body weight at 38 weeks 
compared to ones at term, suggesting that premature infants might display a 
subsequent compensatory kidney hypertrophy. Conversely, we did not found 
differences in TKV/weight at T36 according to GA. Previous studies 215 216 have 
shown that low birth weight is associated with reduced kidney size. Spencer et al 
216 estimated an increase in kidney volume of about 15ml/1,73 m2 for every 
kilogram increase in birth weight. However, we did not found differences in kidney 
volume according to the history of IUGR or SGA, probably due to the low number 
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of IUGR and SGA subjects in our cohort. 
 
Finally, we aimed to assess the possible impact of pre-natal and post-natal 
potentially kidney-detrimental factors on kidney function of preterm newborns. 
Both prenatal and postnatal factors may impair kidney maturation and nephron 
endowment in preterm newborns, since many events potentially impairing renal 
function may occur during the pregnancy and the post-natal clinical course of 
premature infants. In our cohort, we found higher post-natal and total kidney injury 
risk scores in newborns with lower GA, as intuitively foreseeable in more 
premature babies with a longer NICU staying. Therefore, we expected that subjects 
born at a lower GA and facing more potentially kidney-detrimental events in post-
natal life would have an impaired kidney function at T36, as estimated by eGFR. 
Surprisingly, we found a direct correlation between post-natal and total scores and 
eGFR estimated according to Schwartz 2009’s and Brion’s formulas. However, 
these correlations did not persist when adjusted for weight, length and BSA. 
Conversely, no significant correlations were found between the scores and eGFR 
according to the other formulas. Indeed, it has to be pointed out that the Schwartz 
2009’s and the Brion’s formulas rely on sCr values, that are known to be influenced 
by nutritional status and muscle mass. Actually, in our cohort, sCr at T36 was 
significantly lower in subjects with lower GA. Moreover, such correlations did not 
persist also when adjusted for urea levels at T36, probably for the same reasons 
already explained for the inverse correlation between eGFR and GA. eGFR at T36 
does not seem to be influenced by prenatal factors. Moreover, neither prenatal nor 
post-natal factors influenced kidney volumes at T36 in our cohort.  
 
Limitations 
The post-natal variables considered as potentially kidney-detrimental are basically 
hallmarks of a more rough and troubled NICU course. Therefore, they probably 
impair other functions of the preterm organism, and it would be difficult to entangle 
the additive or synergic effects of these alterations. Moreover, due to the limited 
sample number, we could not assess the singular contribution of all the considered 
risk factors on renal function.   
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6. CONCLUSIONS AND FUTURE PERSPECTIVES 
  
As almost 13 million infants worldwide are born prematurely each year, it is 
important to identify those at higher risk for developing CKD due to congenital or 
acquired low nephron number. Therefore, it would be important to find in preterm 
newborns the best biomarker, both in terms of sensitivity and specificity, to identify 
early signs of AKI, as well as of a chronically reduced kidney function.  
Among the new endogenous biomarkers, CysC seems to be particularly promising, 
as it is not influenced by GA, gender or anthropometric parameters soon after birth 
and by gender, anthropometric parameters and nutritional status at 36 weeks of 
post-menstrual age, when nephronic maturation is supposed to be completed. 
However, its measurement is quite expensive and not widely spread. On the other 
hand, sCr is a low-cost and highly available marker, and it would be useful as a 
surrogate of nephron endowment, in the absence of US evaluation of kidney 
volume, at least soon after birth. Therefore, we may conclude that the overall best 
marker of renal function does not exist, but the best one could be chosen according 
to the preterm patient’s characteristics (i.e. GA, post-natal age and others) and 
according to the neonatologist’s clinical query (acute kidney injury, chronic kidney 
disease).   
Finally, in the perspective of the best care for the preterm newborn, it has to be 
highlighted that the potentially damaging events occurring in pre-natal life have 
little if no impact on future kidney health. Conversely, post-natal clinical course 
influences kidney function, but overall importance has to be attributed to the 
nutritional status of preterm infants. Indeed, subjects born at a lower GA but 
receiving more intensive and targeted nutritional interventions have a better renal 
function than subjects with higher GA, who receive parenteral nutrition less 
frequently. 
Future studies are needed to understand which practices during NICU staying need 
to be changed to preserve future kidney function, and to evaluate which nutritional 
strategies would be more protective of renal health. 
Only a long-term follow-up would be able to assess if a mild but precocious 
impairment of renal function would influence kidney function and predispose to 
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the development of arterial hypertension and other non-communicable diseases in 
later-on life. 217 218   
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8. APPENDIX I: Published and accepted papers 
 
